{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["0780de4e-6d8e-40f4-9f17-eea2e9da7c0e", "Q2", 41454, "WILLIAMS AND JENSEN, PLLC", 151200, "ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)", 2016, "second_quarter", "2016-07-12T14:09:09.073000-04:00", 50000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/\", \"filing_uuid\": \"0780de4e-6d8e-40f4-9f17-eea2e9da7c0e\", \"filing_type\": \"Q2\", \"filing_type_display\": \"2nd Quarter - Report\", \"filing_year\": 2016, \"filing_period\": \"second_quarter\", \"filing_period_display\": \"2nd Quarter (Apr 1 - June 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"50000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"TJ Hartten\", \"dt_posted\": \"2016-07-12T14:09:09.073000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"701 8th Street, NW\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20001\", \"registrant\": {\"id\": 41454, \"url\": \"https://lda.senate.gov/api/v1/registrants/41454/\", \"house_registrant_id\": 30771, \"name\": \"WILLIAMS AND JENSEN, PLLC\", \"description\": \"Lobbying Law Firm\", \"address_1\": \"1201 Pennsylvania Avenue, NW\", \"address_2\": \"Suite 800\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"ISABELLA QUINN\", \"contact_telephone\": \"+1 202-659-8201\", \"dt_updated\": \"2026-01-30T10:10:58.206597-05:00\"}, \"client\": {\"id\": 151200, \"url\": \"https://lda.senate.gov/api/v1/clients/151200/\", \"client_id\": 924, \"name\": \"ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DE\", \"state_display\": \"Delaware\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18077, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"GEORGE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OLSEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 37173, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KARINA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LYNCH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 14682, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SUSAN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HIRSCHMANN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 48784, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MATTHEW\", \"nickname\": null, \"middle_name\": \"B\", \"last_name\": \"HOEKSTRA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 65303, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": \"BOOK\", \"last_name\": \"MULLEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 43395, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"MELINDA\", \"nickname\": null, \"middle_name\": \"M\", \"last_name\": \"MAXFIELD\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 61426, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHERYL\", \"nickname\": null, \"middle_name\": \"LYNN\", \"last_name\": \"JAEGER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 10, \"name\": \"Vice President of the U.S.\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"Tax issues affecting the pharmaceutical industry, tax reform issues.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18077, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"GEORGE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OLSEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 10, \"name\": \"Vice President of the U.S.\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB).\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18077, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"GEORGE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"OLSEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 37173, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KARINA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"LYNCH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 65303, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ERIN\", \"nickname\": null, \"middle_name\": \"BOOK\", \"last_name\": \"MULLEN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 15838, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"JACK\", \"nickname\": null, \"middle_name\": \"STEVEN\", \"last_name\": \"HART\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 14682, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"SUSAN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"HIRSCHMANN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 48784, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MATTHEW\", \"nickname\": null, \"middle_name\": \"B\", \"last_name\": \"HOEKSTRA\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 61426, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"CHERYL\", \"nickname\": null, \"middle_name\": \"LYNN\", \"last_name\": \"JAEGER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 10, \"name\": \"Vice President of the U.S.\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["0780de4e-6d8e-40f4-9f17-eea2e9da7c0e"], "units": {}, "query_ms": 18.836716189980507, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}